Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 297 followers
Latest posts
Last updated 4 days ago
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 10, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of...
Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation: 19/09/2019, Revision: 21, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation...
Human medicines European public assessment report (EPAR): Advate, octocog alfa, Date of authorisation: 02/03/2004, Revision: 35, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Advate, octocog alfa, Date of...
Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 40, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date...
Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation: 16/01/2009, Revision: 52, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Striascan, ioflupane (123l), Date of authorisation: 25/06/2019, Revision: 5, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Striascan, ioflupane (123l), Date of...
Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion
Human medicines European public assessment report (EPAR): Vysribli (previously Denosumab Intas), Vysribli, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Vysribli (previously Denosumab Intas), Vysribli...
Human medicines European public assessment report (EPAR): Terrosa, teriparatide, Date of authorisation: 04/01/2017, Revision: 8, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Terrosa, teriparatide, Date of authorisation...
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 12, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation...
Human medicines European public assessment report (EPAR): Jayempi, azathioprine, Date of authorisation: 21/06/2021, Revision: 9, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Jayempi, azathioprine, Date of authorisation...